pTagRFP-zyxin


pTagRFP-zyxin vector

cat.# FP373

The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced.


Download
vector information:
ProductCat.#SizePrice
pTagRFP-zyxinFP37320 μg€ 400.00
The price does not include delivery. The price varies in different countries. Please contact your local distributor for exact prices and delivery information.

Vector typemammalian expression vector
ReporterTagRFP
Reporter codon usagemammalian
Promoter for TagRFPPCMV IE
Host cellsmammalian
Selectionprokaryotic - kanamycin
eukaryotic - neomycin (G418)
Replicationprokaryotic - pUC ori
eukaryotic - SV40 ori
Use red (orange) fluorescent labeling of zyxin

Vector description

pTagRFP-zyxin is a mammalian expression vector encoding TagRFP-zyxin fusion protein (see TagRFP description). The vector can be used for fluorescent labeling of zyxin in living cells.

TagRFP codon usage is optimized for high expression in mammalian cells, i.e. humanized (Haas et al., 1996). Human zyxin is fused to the TagRFP N-terminus.

pTagRFP-zyxin can be used as a source of TagRFP-zyxin hybrid sequence. The vector backbone contains unique restriction sites that permit it excision and further insertion into expression vector of choice.

Note: The plasmid DNA was isolated from dam+-methylated E.coli. Therefore some restriction sites are blocked by methylation. If you wish to digest the vector using such sites you will need to transform the vector into a dam- host and make fresh DNA.

The vector backbone also contains immediate early promoter of cytomegalovirus (PCMV IE) for protein expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in E. coli, and f1 origin for single-stranded DNA production. SV40 polyadenylation signals (SV40 poly A) direct proper processing of the 3' end of the reporter mRNA.

SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in E. coli. Kanr/Neor gene is linked with herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signals.


Expression in mammalian cells

pTagRFP-zyxin can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive expression of the TagRFP-zyxin fusion in eukaryotic cells. If required, stable transformants can be selected using G418 [Gorman, 1985].


Propagation in E. coli

Suitable host strains for propagation in E. coli include DH5alpha, HB101, XL1-Blue, and other general purpose strains. Plasmid incompatibility group is pMB1/ColE1. The vector confers resistance to kanamycin (30 μg/ml) to E. coli hosts. Copy number in E. coli is about 500.


Location of features

PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
Zyxin: 636-2348
TagRFP: 1941-2654
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 2807-2812 & 2836-2841
mRNA 3' ends: 2845 & 2857
f1 single-strand DNA origin: 2904-3359
Bacterial promoter for expression of Kanr gene
-35 region: 3421-3426
-10 region: 3444-3449
Transcription start point: 3456
SV40 origin of replication: 3700-3835
SV40 early promoter
Enhancer (72-bp tandem repeats): 3533-3604 & 3605-3676
21-bp repeats: 3680-3700, 3701-3721 & 3723-3743
Early promoter element: 3756-3762
Major transcription start points: 3752, 3790, 3796 & 3801
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 3884-3886
Stop codon: 4676-4678
G->A mutation to remove Pst I site: 4066
C->A (Arg to Ser) mutation to remove BssH II site: 4412
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 4914-4919 & 4927-4932
pUC plasmid replication origin: 5263-5906


References:

  • Gorman C. High efficiency gene transfer into mammalian cells. In DNA cloning: A Practical Approach, Vol. II. Ed. D. M. Glover. (IRL Press, Oxford, U.K.). 1985; 143–90.
  • Haas J, Park EC, Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol. 1996; 6 (3):315-24. / pmid: 8805248

Notice to Purchaser:

Evrogen FP-related products are intended for research use only and covered by Evrogen Patents and/or Patent applications pending. By use of these products, you accept the terms and conditions of the applicable Limited Use Label License.

The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.

MATERIAL SAFETY DATA SHEET INFORMATION

To the best of our knowledge, these products do not require a Material Safety Data Sheet. However, all the properties of these products (and, if applicable, each of their components) have not been thoroughly investigated. Therefore, we recommend that you use gloves and eye protection, and wear a laboratory coat when working with these products.

Copyright 2002-2008 Evrogen. All rights reserved.
Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, +7(495)4298020, e-mail:evrogen@evrogen.com